. PF cultures were established from 221+/b!% and 118+/bRn BF cells (in the absence of any drug) and were initially determined to be expressing par mRNA and Parp (see Hehl and Roditi, 1994) . No Vsg118 or Vsg221 was detected in these cultures by Western blot analysis ( Figure 48 ; data not shown). The DNA modification found at telomeric loci in BF cells, exemplified by Pstl digestion, is absent from PF cells (Pays et al., 1984) . Southern blot analysis with a vsg227 probe confirmed that DNA modification was no longer detectable in PF cells derived from 118'lbRn BF cells (data not shown). Regard- The b/e gene was flanked by actin (act) sequences, which allow constitutive expression in both life cycle stages (Hug et al., 1993) . Lack of detectable b/e mRNA or Ble (the Streptoalloteichus hindustanus phleomycin resistance protein) showed that transcription from the endogenous ES promoter was attenuated in PF cells, as expected (Rudenko et al., 1994) . The presence of high levels of neo mRNA and Neo (neo phosphotransferase) in both PF clones showed that transcription from the rRNA promoter was derepressed in 118+/bRn PF cells. The neo mRNA level in 221 +/bRn BF cells was 12-fold higher than in both PF types, when measured by phosphorimaging. The neo gene was flanked by aldolase (a/d) sequences. a/d mRNA is at least 6-fold less abundant in PF cells than in BF cells (Vijayasarathy et al., 1990) , and this effect appears to be mediated by the 3' untranslated region (Hug et al., 1993) . The difference between neo mRNA levels in 221 +/bRn BF cells and 118'lbRn or 221 +/bRn PF cells may therefore be attributed to mRNA stability, processing differences, or both, mediated by the a/d 3' untranslated region. There were no measurable differences in Neo levels between PF cells and BF cells, however, suggesting differences in translation efficiency or Neo stability between PF and BF cells. 1994). We were interested to see whether this was also the case for an ES promoter at the site of integration used in these experiments. 221a ceils were transformed with pbEn. These cells, designated 221+/bEn BF cells, exhibited the same high level resistance to G418 and phleomycin as did 221+/bRn BF cells. 2217bEn BF cells were differentiated to PF cells, and both developmental stages were analyzed by Western blotting (data not shown). Transcription from the inserted ES promoter, present in the previously active ES, was also repressed upon differentiation to PF cells. Because this was a negative result, we sequenced the 315 bp promoter element in the pbEn plasmid and confirmed that it was unchanged from the sequence used in transient transfection experiments (Zomerdijk et al., 1990) . We also showed that this 315 bp promoter sequence generates increased reporter gene expression at another chromosomal locus (unpublished data).
The Stability of the Repressed State The rRNA, Parp, and ES promoters generated relatively low level expression of neo and vsg227 in the vsg227 locus in BF cells expressing Vsgl18. We wanted to know whether this was due to low level expression in all cells or high level expression in a subpopulation.
Indirect immunofluorescence analysis of the 118+/bRn BF population revealed no cells expressing a detectable level of Vsg221, while >99% expressed Vsgl18. This suggested that transcription from the rRNA promoter was repressed in all of the cells.
To examine larger numbers of cells in populations with transcription repressed from all three promoters, we took advantage of drug selection assays. Using previously determined IC5,, values as a guide, we selected cells from these populations that had become resistant to 50 uglml G418 or 2 uglml phleomycin. Resistant cells arose at a frequency of <10e6 in each of the three populations (118+/ bRn, 1 18+/bPn, and 1187bEn BF cells). Using phleomycin, we expected to select for cells in which transcription from the endogenous ES promoter was activated in situ or in which the cassette was duplicated or otherwise translocated downstream of a productive promoter. Using G418, we expected to select similar events and for the independent activation of transcription from the inserted promoter. The results indicated that transcription from all three promoters was repressed in the vast majority of cells and that all possible activation events occurred at a frequency of <10e6. The results also indicated that the repressed state is efficiently inherited. Cells that became resistant to either drug in these assays no longer expressed Vsgl18 but expressed levels of Ble, Neo, and Vsg221 equivalent to 221+/bRn BF cells, indicating a switch to the 221 ES (unpublished data).
We used a similar approach to determine the cellular status of low level b/e expression in 118+/bRn and 221+1 bRn PF populations, which have an rRNA promoter driving neo expression, and the low level b/e and neo expression in 118+/bEn and 221+/bEn PF populations, which have a repressed ES promoter driving low level neo expression.
A phleomycin concentration was determined to which PF cells derived from wild-type 118a or 221a BF cells were sensitive. Cells (1 06) of each clone were transferred into medium containing 20 uglml phleomycin. All four PF populations (118+/bRn, 221+/bRn, 118+/bEn, and 221+/bEn) were killed within a few days, and no live cells were detected after 20 days, suggesting that any transcription from the endogenous ES promoter was efficiently suppressed in every cell. A G418 concentration was determined to which 118'lbRn and 221+/bRn PF cells were resistant, while PF cells derived from wild-type 118a or 221 a BF cells were sensitive. Between 1 x IO6 and 5 x lo6 118+/bEn or 221 'IbEn PF cells were transferred into medium containing 100 uglml G418. After 2 weeks, populations of G418-resistant cells persisted in both cultures. By indirect immunofluorescence, we confirmed the presence of <0.5% of cells abundantly expressing Neo in the 118+/ bEn PF population, prior to drug selection. Selection of G418-resistant cells from two independent populations and detection of Neo-expressing cells prior to drug selection suggest that marker gene expression is due to intrinsic heterogeneity within the population rather than to selection of mutants. These results indicate that the inserted telomere-proximal ES promoter escapes transcription repression in a PF subpopulation.
Discussion
Identical promoter sequences can be transcriptionally active or repressed in the same nucleus, depending upon their chromosomal location (Nasmyth et al., 1981) . Various forms of "silencing" have been described in a number of organisms (reviewed by Laurenson and Rine, 1992) and have been studied extensively in yeast. Telomere position effect is a form of silencing exerted on RNA polymerase II promoters in the vicinity of S. cerevisiae telomeres (Gottschling et al., 1990) . Telomere position effect is mitotitally heritable, but reversible. In our experiments, a mitotitally heritable position effect was observed on transcription from three promoters inserted close to a telomere, at the vsg227 locus in BF cells expressing Vsg118. Our observations suggest that an effect similar to telomere position effect in yeast may be regulating transcriptional silencing in T. brucei. In yeast, silencing spreads only -5 kb from the telomere (Gottschling et al., 1990) . This distance can be increased to 22 kb by altering the amount of transacting factors in the cell (Renauld et al., 1993) . In T. brucei, a chromatin structure initiated at a telomere would have to be propagated over even longer distances to repress transcription from endogenous ES promoters.
In T. brucei, pre-mRNA acquires a 5' cap by transsplicing, allowing RNA polymerase I to mediate the efficient production of mRNA. RNA polymerase I is likely to be responsible for transcription from rRNA, Parp, and ES promoters in T. brucei (reviewed by Chung et al., 1992) . All three promoters generated similar reporter activities when incorporated into plasmids and transfected into PF cells (Zomerdijk et al., 1991) . A number of stable transformation experiments have also been carried out in PF cells. (Cross, 1975; Johnson and Cross, 1979) were cultured in HMI-9 at 37% (Hirumi and Hirumi, 1994) . BF cells were differentiated to PF ceils by transferring 1 x lo7 cells into DTM with 10 mM glycerol, 5.5 mM proline, 15% FBS, and 3 mM citric acid cycle intermediates at 27% (Overath et al., 1986) . PF cultures were established for at least 2 weeks prior to analysis. G418 was from GIBCO BRL, and phleomycin was from CayLa.
Plasmid Constructions Splice acceptor and polyadenylation signals (Hug et al., 1993) were placed either side of the S. hindustanus b/e gene (Drocourt et al., 1990) . The act splice acceptor was a Smal-Hindlll fragment and was inserted at the Hpal site in pUT56 (CayLa). The act polyadenylation signal was a BamHI-Pstl fragment that was subsequently inserted at the Stul site in the resulting construct.
A 519 bp Hindlll-BamHI fragment containing the rRNA promoter (White et al., 1986) was placed downstream of the b/e cassette at the Notl site. The entire Ndel-Sacll cassette was then inserted at a Smal site in pBYANA5'(V.
B. Carruthers and G. A. M. C., unpublished data) to generate a cassette cbntaining an rRNA promoter flanked by a selectable marker upstream (b/e) and downstream (neo). The vsg227 targeting plasmid was made from pBYANA5'by removing a Sacl-Clal fragment.
The entire b/e-rRNA promoter-neo (bRn) Clal-BstEll cassette was then inserted at an EcoRl site in the vsg227 target sequence to generate pbRn. To replace the rRNA promoter with T. brucei Parp and ES promoters, we digested pbRn with Sfil and then partially digested pbRn with EcoRI. The Parp (locus A) promoter was on a 390 bp Apal-Smal fragment from pT1 I-bs (Patnaik et al., 1993) , and the ES promoter was on a 315 bp Hpal-Sall fragment from pRKB(+) (Zomerdijk et al., 1991) . Insertion of these promoters generated pbPn and pbEn, respectively.
Transformation
and Cloning of BF T. brucei Plasmid DNA for transfection was prepared using anion exchange columns (Qiagen Incorporated).
Plasmids were digested with XholKpnl prior to electroporation.
BF cells were transformed as previously described (Carruthers et al., 1993) . G418 (1 Nglml) was added to the culture 16 hr afler electroporation.
Cloned cell lines were derived from drug-resistant cultures as described previously (Carruthers and Cross, 1992) . Cultures were subsequently grown in the absence of drug, unless otherwise stated.
RNA and DNA Analysis Southern blot analysis indicated that a single copy of each cassette had integrated at the intended position in all of the cloned transformants described.
Genomic DNA was isolated as described previously (Hartree and Bellofatto, 1995) . RNA was isolated using RNAzol B (TelTest Incorporated).
Southern and Northern blot analyses were carried out according to standard protocols (Sambrook et al., 1989) , and all posthybridization washes were at 65'C in 0.2 x SSC and 0.2% SDS. Hybridization signals were quantitated using a phosphorimager and lmagequant software (Molecular Dynamics). Pstl digests were with a IO-fold excess of enzyme to ensure maximum digestion of potentially modified DNA (Bernards et al., 1984b; Pays et al., 1984) .
Protein Analysis Protein concentrations were determined to be similar on Coomassiestained gels, and Western blot analysis was carried out according to standard protocols (Sambrook et al., 1989) . For indirect immunofluorescence, cells were fixed in 1% (v/v) formaldehyde at 4OC for at least 24 hr. After washing twice in PBS and once in 1% (w/v) BSA, cell suspensions
